Other names: Guillain–Barré–Strohl syndrome, Landry's paralysis, postinfectious polyneuritis, Acute Inflammatory Demyelinating Polyneuropathy[1]
Pronunciation: .mw-parser-output .plainlist ol,.mw-parser-output .plainlist ul{line-height:inherit;list-style:none;margin:0;padding:0}.mw-parser-output .plainlist ol li,.mw-parser-output .plainlist ul li{margin-bottom:0}UK:/ˈɡiːjæ̃ˈbæreɪ/US:/ˌɡiˈlænˌbɑːˈreɪ/[2].mw-parser-output .IPA-label-small{font-size:85%}.mw-parser-output .references .IPA-label-small,.mw-parser-output .infobox .IPA-label-small,.mw-parser-output .navbox .IPA-label-small{font-size:100%}French:[ɡilɛ̃baʁe]
Specialty: Neurology
Symptoms: Muscle weakness beginning in the feet and hands, usually ascending[3]
Complications: Breathing difficulties, heart and blood pressure problems[1][3]
Usual onset: Rapid (hours to weeks)[3]
Causes: Typically triggered by an infection; occasionally by surgery and by vaccination
Diagnostic method: Based on symptoms,nerve conduction studies,lumbar puncture[3]
Treatment: Supportive care,intravenous immunoglobulin,plasmapheresis
Prognosis: Weeks to years for recovery[3]
Frequency: 2 per 100,000 people per year[3][4]
Deaths: 7.5% of those affected[1]
Named after: Georges GuillainJean Alexandre Barré
